Page 38 - APED 2018 N2

21. Glyn-Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Wein- ans H, et al. Osteoarthritis. Lancet. 2015;386:376-87.
22. Abedi M, Kambar P, Afshari M, Mirkazemi M. Comparison of the Effectiveness of Intra-Articular Injections of Hyaluronic Acid and Corticosteroid in the Treatment of Patients with Knee Osteoarthritis Symptomse. Ortho & Rheum Open Access J. 2017;7(1):OROAJ. MS.ID.555704.
23. Uthman I, Raynauld J, Haraoui B. Intra-articular therapy in osteoar- thritis. Post-graduate Med J. 2003;79:449-53.
24. Bert J, Bert T. Nonoperative treatment of unicompartimental arthritis. From bracing to injection. Clin Sports Med. 2014;33:1-10.
25. Filardo G. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19:528-35.
26. Anitua E, Prado R, Sanchez M, Orive G. Platelet-Rich Plasma: Prep- aration and Formulation. Oper Tech Orthop. 2012;22:25-32.
27. Demange M, Sisto M, Rodeo S. Future trends for unicompartimental arthritis of the knee. Injectables & stem cells. Clin Sports Med. 2014;33:161-74.
28. Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective, Journal of Cutaneous and Aesthetic Surgery. 2014;7(4):189-97.
T. Rodrigues, et al.: Eficácia da BoNT-A na OA do Joelho 29. Mascarenhas R, Saltzman BM, Fortier LA, Cole BJ. Role of platelet
rich plasma in articular cartilage injury and disease. J Knee Surg.
2015;28(1);3-10.
30. Mahowald ML, Krug HE, Singh, Dykstra D. Intra-articular Botulinum
Toxin Type A: A new approach to treat arthritis joint pain. Toxicon.
2009;54(5):658-67.
31. Singh JA, Mahowald ML, Kushnaryov A, Goelz E, Dystra D. Repeat
Injections of Intra-Articular Botulinum Toxin A for the Treatment of
Chronic Arthritis Joint Pain. J Clin Rheumatol. 2009;15(1):35-8.
32. Dworkin R, Backonja M, Rowbotham M, et al. Intra-articular Botuli- num Toxin Type A: A new approach to treat arthritis joint pain, Ad-
vances in neuropathic pain. Arch. Neurol. 2003;60(1):524-34,
33. Farrar JT, et al, Intra-articular Botulinum Toxin Type A: A new ap- proach to treat arthritis joint pain. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating
scale. Pain. 2001;94(2):149-58.
34. Farrar JT, Young Jr. JP, LaMoreaux L, Werth JL, Poole RM. Intra-
articular Botulinum Toxin Type A: A new approach to treat arthritis joint pain. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001; 94(2):149-58.
37
DOR